Skip to search formSkip to main contentSkip to account menu

JM-8

Known as: JM 8, JM8 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Carboplatin
Paraplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
Summarycis-Diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8), an analogue of cisplatin showing reduced toxicity in… 
2004
2004
Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma
SummarySeventeen patients with malignant mesothelioma were treated in a phase II study with carboplatin, a cisplatin analogue… 
Highly Cited
1987
Highly Cited
1987
The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
Highly Cited
1987
Highly Cited
1987
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
Fifty-two previously untreated patients with small-cell lung carcinoma (SCLC) were treated with a combination of carboplatin 300… 
1987
1987
Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40).
Highly Cited
1986
Highly Cited
1986
Ototoxicity of Cisplatin vs. Platinum Analogs CBDCA (JM-8) and CHIP (JM-9)
Cis-diamminedichloroplatinum (cisplatin), a divalent platinum compound and cell-cycle nonspecific chemotherapeutic agent… 
Highly Cited
1985
Highly Cited
1985
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8).
Between 1978 and 1983, 44 patients with advanced seminoma were treated with cis-platinum-based combination chemotherapy (39… 
Highly Cited
1985
Highly Cited
1985
Ovarian trials at the Royal Marsden.
Highly Cited
1984
Highly Cited
1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
cis-Diammine-1,1-cyclobutane dicarboxylate platinum(II) (CBDCA, JM8) is a nonnephrotoxic analogue of cisplatin currently… 
Highly Cited
1983
Highly Cited
1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.
A phase II study of JM8, an analog of cisplatin, has been carried out in 36 patients with advanced ovarian carcinoma. Thirty… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)